Go Pro

Zevra Therapeutics (ZVRA) Institutional Ownership

Zevra Therapeutics logo
$13.18 -0.17 (-1.27%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$13.17 -0.01 (-0.11%)
As of 04:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Zevra Therapeutics (NASDAQ:ZVRA)

Current
Institutional Ownership
Percentage
35.03%
Number of
Institutional Buyers
(last 12 months)
85
Total
Institutional Inflows
(last 12 months)
$116.82M
Number of
Institutional Sellers
(last 12 months)
38
Total
Institutional Outflows
(last 12 months)
$49.48M
Get ZVRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ZVRA Institutional Buying and Selling by Quarter

Zevra Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/9/2026 Hennion & Walsh Asset Management Inc.383,706$5.50M0.2%+116.6%0.649%
5/20/2026Arete Wealth Advisors LLC66,397$617K0.0%-4.8%0.112%
5/19/2026Bank of America Corp DE64,837$604K0.0%-55.7%0.110%
5/19/2026Arete Wealth Advisors LLC66,397$617K0.0%-4.8%0.112%
5/16/2026The Manufacturers Life Insurance Company 15,137$141K0.0%-10.4%0.026%
5/16/2026Quantinno Capital Management LP32,022$298K0.0%+114.1%0.054%
5/7/2026Dimensional Fund Advisors LP554,802$5.17M0.0%+259.2%0.938%
5/5/2026Bank of New York Mellon Corp172,427$1.61M0.0%-1.0%0.292%
5/5/2026Sanctuary Advisors LLC18,490$172K0.0%-46.3%0.031%
4/30/2026AIGH Capital Management LLC1,200,000$11.18M1.5%N/A2.030%
4/27/2026Simplify Asset Management Inc.100,630$938K0.0%+137.5%0.170%
4/22/2026Janney Montgomery Scott LLC236,834$2.21M0.0%+16.7%0.403%
3/5/2026Gunpowder Capital Management LLC dba Oliver Wealth Management5,891$53K0.0%N/A0.010%
2/24/2026DGS Capital Management LLC14,810$133K0.0%N/A0.026%
2/18/2026NewEdge Advisors LLC4,000$36K0.0%-82.1%0.007%
2/18/2026Wellington Management Group LLP170,309$1.53M0.0%-9.1%0.303%
2/18/2026Polymer Capital Management US LLC17,123$153K0.0%-46.0%0.030%
2/18/2026Millennium Management LLC1,134,358$10.16M0.0%+9.6%2.015%
2/18/2026Man Group plc92,347$827K0.0%+174.4%0.164%
2/18/2026Engineers Gate Manager LP44,020$394K0.0%+23.4%0.078%
2/18/2026683 Capital Management LLC905,000$8.11M0.4%-7.2%1.607%
2/17/2026Schonfeld Strategic Advisors LLC13,824$124K0.0%N/A0.025%
2/17/2026AQR Capital Management LLC181,129$1.62M0.0%+18.9%0.322%
2/17/2026Trexquant Investment LP209,704$1.88M0.0%-30.8%0.372%
2/17/2026Price T Rowe Associates Inc. MD32,140$288K0.0%+12.8%0.057%
2/17/2026Adage Capital Partners GP L.L.C.275,000$2.46M0.0%-87.6%0.488%
2/17/2026Royal Bank of Canada4,582$42K0.0%-52.7%0.008%
2/17/2026Carret Asset Management LLC54,000$484K0.0%-5.3%0.096%
2/16/2026Squarepoint Ops LLC317,066$2.84M0.0%+18.3%0.563%
2/16/2026Verition Fund Management LLC17,704$159K0.0%-90.9%0.031%
2/16/2026Barclays PLC100,135$897K0.0%-69.9%0.178%
2/13/2026Arete Wealth Advisors LLC69,769$625K0.0%-6.1%0.124%
2/13/2026Nantahala Capital Management LLC1,771,936$15.88M0.5%-10.1%3.147%
2/13/2026Marshall Wace LLP669,742$6.00M0.0%-26.6%1.190%
2/13/2026The Manufacturers Life Insurance Company 16,896$151K0.0%-9.5%0.030%
2/13/2026Schroder Investment Management Group506,033$4.46M0.0%+22.7%0.899%
2/13/2026Rafferty Asset Management LLC15,920$143K0.0%+34.0%0.028%
2/13/2026Charles Schwab Investment Management Inc.180,618$1.62M0.0%+14.5%0.321%
2/13/2026State Street Corp1,482,956$13.29M0.0%+3.9%2.634%
2/13/2026Wells Fargo & Company MN66,950$600K0.0%+81.7%0.119%
They proved it worked in '76. Then buried it. (Ad)

In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the project. Unocal and Texaco did the same. All three buried the results because it threatened their core business. Now one company has spent sixty years developing what Big Oil refused to touch. Google locked in a 15-year contract, Bill Gates wrote a $100 million check, and on August 18th the government hands it a competitive edge no other energy source receives.tc pixel

Discover the company that spent 60 years proving this technology works
2/12/2026MetLife Investment Management LLC27,867$250K0.0%+10.5%0.049%
2/12/2026Commonwealth Equity Services LLC14,229$127K0.0%-45.2%0.025%
2/12/2026Dimensional Fund Advisors LP154,466$1.38M0.0%N/A0.274%
2/12/2026EntryPoint Capital LLC52,871$474K0.2%+83.1%0.094%
2/12/2026Integrated Quantitative Investments LLC56,128$503K0.1%N/A0.100%
2/12/2026Federated Hermes Inc.23,453$210K0.0%+17.8%0.042%
2/12/2026Nuveen LLC143,132$1.28M0.0%-6.5%0.254%
2/11/2026Janney Montgomery Scott LLC202,883$1.82M0.0%+10.4%0.360%
2/11/2026Deutsche Bank AG45,939$412K0.0%+4.4%0.082%
2/11/2026Fox Run Management L.L.C.24,722$222K0.0%-20.3%0.044%
2/11/2026JPMorgan Chase & Co.412,261$3.69M0.0%-6.1%0.732%
2/11/2026Los Angeles Capital Management LLC54,454$488K0.0%-7.0%0.097%
2/11/2026Propel Bio Management LLC63,683$571K0.5%-72.5%0.113%
2/11/2026WINTON GROUP Ltd26,089$234K0.0%+114.5%0.046%
2/10/2026Northwestern Mutual Wealth Management Co.15,000$134K0.0%N/A0.027%
2/9/2026Geode Capital Management LLC1,341,681$12.03M0.0%+3.2%2.383%
2/9/2026Royce & Associates LP865,822$7.76M0.1%+25.3%1.538%
2/9/2026Legal & General Group Plc1,097,988$9.84M0.0%+4.2%1.950%
2/9/2026Simplify Asset Management Inc.42,365$380K0.0%-71.2%0.075%
2/9/2026Jefferies Financial Group Inc.120,000$1.08M0.0%N/A0.213%
2/6/2026ProShare Advisors LLC12,669$114K0.0%+12.3%0.023%
2/4/2026Bailard Inc.12,900$116K0.0%N/A0.023%
1/29/2026UBS Group AG285,488$2.56M0.0%+30.9%0.507%
1/29/2026Sanctuary Advisors LLC34,461$309K0.0%+18.0%0.061%
1/28/2026Retirement Planning Co of New England Inc.662,976$5.94M2.4%+10.4%1.178%
1/20/2026Stratos Wealth Partners LTD.409,000$3.67M0.0%+78.6%0.726%
1/14/2026 Hennion & Walsh Asset Management Inc.139,591$1.25M0.0%N/A0.248%
1/9/2026SG Americas Securities LLC13,543$121K0.0%N/A0.024%
1/1/2026JPMorgan Chase & Co.438,984$4.18M0.0%+1,458.8%0.780%
12/1/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%
11/17/2025NewEdge Advisors LLC22,338$212K0.0%+458.5%0.040%
11/17/2025Caxton Associates LLP17,317$165K0.0%N/A0.031%
11/17/2025Woodline Partners LP3,476,143$33.06M0.2%-24.7%6.175%
11/17/2025PharVision Advisers LLC66,733$635K0.4%N/A0.119%
11/17/2025XTX Topco Ltd66,381$631K0.0%N/A0.118%
11/17/2025Verition Fund Management LLC193,509$1.84M0.0%N/A0.344%
11/17/2025Polymer Capital Management US LLC31,698$301K0.0%+89.4%0.056%
11/17/2025Quarry LP10,883$103K0.0%N/A0.019%
11/17/2025Qube Research & Technologies Ltd306,489$2.92M0.0%+2,615.2%0.544%
11/17/2025Prelude Capital Management LLC15,600$148K0.0%N/A0.028%
11/17/2025Nantahala Capital Management LLC1,971,936$18.75M0.7%+34.0%3.503%
11/17/2025Millennium Management LLC1,035,251$9.85M0.0%+63.1%1.839%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,896$237K0.0%-17.7%0.044%
11/17/2025Integrated Wealth Concepts LLC15,081$143K0.0%N/A0.027%
11/17/2025Kingdon Capital Management L.L.C.650,000$6.18M0.8%+44.4%1.155%
11/17/2025Brevan Howard Capital Management LP130,751$1.24M0.0%N/A0.232%
11/17/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%
11/17/2025Bank of America Corp DE288,045$2.74M0.0%+28.7%0.512%
11/17/2025Boothbay Fund Management LLC14,943$142K0.0%N/A0.027%
11/17/2025Aquatic Capital Management LLC28,593$272K0.0%-11.5%0.051%
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (Ad)

In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.tc pixel

See Jim Rickards' full market warning and what it means for your portfolio
11/17/2025Algert Global LLC418,550$3.98M0.1%N/A0.743%
11/14/2025Raymond James Financial Inc.23,306$222K0.0%-13.4%0.041%
11/14/2025Virtu Financial LLC62,740$597K0.0%N/A0.111%
11/14/2025Man Group plc33,652$320K0.0%N/A0.060%
11/14/2025Squarepoint Ops LLC268,077$2.55M0.0%N/A0.476%
11/13/2025Marshall Wace LLP912,299$8.68M0.0%N/A1.620%
11/13/2025UBS Group AG218,096$2.07M0.0%+41.5%0.387%
11/13/2025BNP Paribas Financial Markets10,993$105K0.0%-74.4%0.020%
11/13/2025Franklin Resources Inc.36,835$350K0.0%N/A0.065%
11/13/2025Legal & General Group Plc1,053,399$10.02M0.0%+12.6%1.871%


ZVRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 121 institutional investors and hedge funds held shares of Zevra Therapeutics. The most heavily invested institutionals were Woodline Partners LP ($33.06M), Vanguard Group Inc. ($29.32M), Rubric Capital Management LP ($17.25M), FMR LLC ($16.05M), Nantahala Capital Management LLC ($15.88M), State Street Corp ($13.29M), and Geode Capital Management LLC ($12.03M).Learn more on Zevra Therapeutics' institutional investors.

35.03% of Zevra Therapeutics' stock is owned by institutional investors. Learn more on ZVRA's institutional investor holdings.

Of the 110 institutional investors that purchased Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($3.55M), AIGH Capital Management LLC ($2.64M), FMR LLC ($2.31M), Marshall Wace LLP ($912.30K), Stonepine Capital Management LLC ($877.92K), Royce & Associates LP ($865.82K), and JPMorgan Chase & Co. ($830.87K).

Institutional investors have bought a total of 12,493,100 shares in the last 24 months. This purchase volume represents approximately $116.82M in transactions.

Of the 38 institutional investors that sold Zevra Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.95M), Woodline Partners LP ($1.14M), AIGH Capital Management LLC ($519.22K), Marshall Wace LLP ($242.56K), Barclays PLC ($232.31K), Nantahala Capital Management LLC ($200K), and Verition Fund Management LLC ($175.81K).

Institutional investors have sold a total of 5,453,250 shares in the last 24 months. This volume of shares sold represents approximately $49.48M in transactions.



This page (NASDAQ:ZVRA) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners